Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now

Learn more about CME

Stenting During Percutaneous Coronary Intervention (PCI)

MoreVert
AddCircleOutlineFollow
ShareShare
AddCircleOutlineFollow
Follow
ShareShare
Share

You must be a subscriber to see the full topic content.

  • KeyboardArrowRight

    Overview and Recommendations

    • Background

    • Evaluation

    • Management

  • Related Summaries

  • Overview

  • General Description

  • Recommendations for Stenting

  • KeyboardArrowRight

    Efficacy of Stenting vs. No Stenting

    • Stenting during PCI for stable coronary artery disease

    • Stenting during PCI for acute myocardial infarction

  • KeyboardArrowRight

    Efficacy of Drug-Eluting Stents vs. Bare-Metal Stents

    • KeyboardArrowRight

      Drug-eluting stents vs. bare-metal stents

      • Use in various patient populations

      • Use in patients with ST-elevation myocardial infarction

      • Use in patients with saphenous vein grafts

      • Use in patients with diabetes

      • Use in patients on dialysis

      • Use in elderly patients

    • Everolimus-eluting stents vs. bare-metal stents

    • Zotarolimus-eluting stents vs. bare-metal stents

    • Biolimus-eluting stents vs. bare-metal stents

    • Sirolimus-eluting stents vs. bare-metal stents

    • Paclitaxel-eluting stents vs. bare-metal stents

  • KeyboardArrowRight

    Comparisons Between Drug-Eluting Stents

    • Comparison of second- vs. first-generation stents

    • Everolimus-eluting stents vs. other drug-eluting stents

    • Zotarolimus-eluting stents vs. other drug-eluting stents

    • KeyboardArrowRight

      Sirolimus-eluting stents vs. other drug-eluting stents

      • Use in various patient populations

      • Use in patients with diabetes

      • Use in patients with ST-elevation myocardial infarction

    • Polymer-Free Sirolimus-eluting stents vs. other drug-eluting stents

    • Comparisons of other drug-eluting stents

  • Comparisons between stents of different strut thickness

  • KeyboardArrowRight

    Bioabsorbable/bioresorbable and biodegradable polymer stents

    • KeyboardArrowRight

      Stents with bioabsorbable/bioresorbable scaffolds

      • Everolimus-eluting stents (EES) with bioabsorbable vascular scaffold

      • Paclitaxel-eluting stents with bioresorbable polymer

      • Paclitaxel-eluting stents with absorbable metal scaffold

      • Bioresorbable sirolimus-eluting stents

      • Bioabsorbable sirolimus-eluting stents

    • KeyboardArrowRight

      Stents with biodegradable polymers

      • Biolimus-eluting stents with biodegradable polymer

      • Sirolimus- or everolimus-eluting stents with biodegradable polymer

      • Biodegradable magnesium stents

  • KeyboardArrowRight

    Drug-eluting Stents for Restenosis

    • Drug-eluting stents vs. balloon angioplasty

    • Drug-eluting stents vs. angioplasty plus vascular brachytherapy

    • Comparisons between drug-eluting stents

    • Different drug-eluting stent vs. same drug-eluting stent

  • Drug Coating of Stents or Balloon Catheters

  • Mesh-Covered Stent

  • KeyboardArrowRight

    Procedural Considerations

    • Complex versus simple strategy

    • Intravascular ultrasound guidance for stent implantation

    • Other guidance techniques

    • Other considerations

  • Postprocedural Considerations

  • Antiplatelet and Anticoagulant Drugs for Elective PCI

  • Adverse Effects

  • Monitoring

  • KeyboardArrowRight

    Quality Improvement

    • Choosing Wisely Italy

  • KeyboardArrowRight

    Guidelines and Resources

    • KeyboardArrowRight

      Guidelines

      • United States guidelines

      • United Kingdom guidelines

      • European guidelines

    • Review articles

  • Patient Information

  • KeyboardArrowRight

    References

    • General references used

    • Recommendation grading systems used

    • Synthesized Recommendation Grading System for DynaMed

    • DynaMed Editorial Process

    • Special acknowledgements

    • How to cite

Topic Editor
Pinak Shah MD
KeyboardArrowDown
Affiliations

Assistant Professor of Internal Medicine, Harvard Medical School; Massachusetts, United States

Recommendations Editor
Esther Jolanda van Zuuren MD
KeyboardArrowDown
Affiliations

Head of Allergy, Dermatology, and Venereology, Leiden University Medical Centre; Netherlands

Conflicts of Interest

Dr. van Zuuren declares no relevant financial conflicts of interest.

Deputy Editor
Peter Oettgen MD
KeyboardArrowDown
Affiliations

Editor in Chief, DynaMed; Cardiologist, Beth Israel Deaconess Medical Center; Massachusetts, United States; Associate Professor of Medicine, Harvard Medical School; Massachusetts, United States

Conflicts of Interest

Dr. Oettgen declares no relevant financial conflicts of interest.

CheckCircle

top